Myocardial fibrosis evaluated by diffusion‐weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy
- 30 March 2018
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 48 (4) , 1139-1146
Abstract
Background: Previous studies have shown that diffusion‐weighted imaging (DWI) is sensitive to myocardial fibrosis in ischemic and nonischemic cardiomyopathy.Purpose: To explore the prognostic value of apparent diffusion coefficient (ADC) for detecting myocardial fibrosis and its relationship to the contractile function in hypertrophic cardiomyopathy (HCM).Study Type: Prospective.Population: A total of 45 HCM patients and 20 controls.Field Strength/Sequence: 3.0T cardiac MRI. The cardiac MR sequences included cine, T1 mapping, and DWI.Assessment: According to the presence of late gadolinium enhancement (LGE) and the extracellular volume (ECV) values (+2 SD of control subjects), respectively, reader W and reader J assessed the value of ADC of each segment for detecting myocardial fibrosis and its relationship to impaired contractile function in HCM patients.Statistical Tests: Independent sample t‐test, Pearson analysis, and intraclass correlation (ICC).Results: The value of ECV was 23.6 ± 3.0% for control. ECV ≥ 29.6% and ECV < 29.6% groups were classified. ADC values in the ECV ≥ 29.6% group were significantly increased compared to the ECV < 29.6% group, (2.41 ± 0.23 μm2/ms vs. 2.03 ± 0.16 μm2/ms, P < 0.005). Compared to the LGE – group, ECV (32.1 ± 2.3% vs. 29.0 ± 2.8%, P < 0.005) and ADC (2.60 ± 0.18 μm2/ms vs. 2.10 ± 0.07 μm2/ms, P < 0.005) values were significantly increased in the LGE + group. ADC values were linearly associated with ECV values (R2 = 0.65) in HCM patients. ADC values were linearly associated with circumferential and longitudinal strain (R2 = 0.60, R2 = 0.46), as well as circumferential, longitudinal, and radial strain rate (R2 = 0.13, R2 = 0.25, R2 = 0.17, respectively).Data Conclusion: Contractile dysfunction in HCM is predominantly associated with ADC, which is a feasible alternative to ECV and LGE for detecting myocardial fibrosis.Level of Evidence: 1Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2018;48:1139–1146.Keywords
Funding Information
- National Natural Science Foundation of China (Youth Program 81401403)
This publication has 34 references indexed in Scilit:
- Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular VolumeCirculation: Cardiovascular Imaging, 2013
- T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular HypertrophyCirculation: Cardiovascular Imaging, 2013
- Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic CardiomyopathyJACC: Cardiovascular Imaging, 2012
- Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathologyEuropean Heart Journal, 2012
- Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic CardiomyopathyCirculation: Heart Failure, 2010
- Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic ResonanceJACC, 2009
- The genetics of hypertrophic cardiomyopathy: Teare reduxHeart, 2007
- Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heartMagnetic Resonance in Medicine, 2004
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Force-velocity-length relations in hypertrophic cardiomyopathy: Evidence of normal or depressed myocardial contractilityThe American Journal of Cardiology, 1983